研究者業績

大庭 賢二

オオバ ケンジ  (Kenji Ohba)

基本情報

所属
自治医科大学 分子病態治療研究センター 遺伝子治療研究部 講師
学位
博士(医学)(2008年3月 東京医科歯科大学)

研究者番号
20759576
ORCID ID
 https://orcid.org/0000-0002-4936-8186
J-GLOBAL ID
201501081538096585
Researcher ID
D-8072-2015
researchmap会員ID
B000246215

外部リンク

論文

 40
  • Yogo Sakakibara, Kyohei Okahara, Jungo Kakuta, Kazumi Emoto, Yuri Ofusa, Kenji Ohba
    bioRxiv 2026年5月28日  最終著者責任著者
    Reactive astrocytes contribute to neuroinflammation and synaptic dysfunction, but it remains unclear whether transient inflammatory stimulation causes a persistent reactive state after the initial inflammatory stimulus is removed. Here, we investigated whether transient exposure to a defined inflammatory cytokine/complement cocktail induces a persistent reactive astrocyte state and examined the signaling mechanism underlying its maintenance. Human astrocytes were exposed to the inflammatory stimulus and subsequently subjected to stimulus washout, followed by time-course analyses to compare the reversibility of inflammatory gene expression after stimulus removal. Following washout, the expression of several inflammatory response genes, including CXCL10 and NF-κB-associated genes such as NFKBIA, TNFAIP3, and RELB, returned toward baseline levels. In contrast, C3 expression remained elevated, indicating persistence of a post-inflammatory C3-high astrocyte state after withdrawal of the inflammatory stimulus. Pharmacological inhibition of JAK signaling reduced persistent C3 expression to near-baseline levels, supporting the involvement of JAK-dependent signaling in maintenance of this persistent state. Together, these findings suggest that transient inflammatory stimulation induces a post-inflammatory persistent C3-high astrocyte state that is maintained even after broader inflammatory gene responses have subsided. This persistent C3-high component is pharmacologically attenuated by JAK inhibition, identifying JAK-dependent pathways as modulators of persistent astrocyte inflammatory reactivity.
  • Yuri Ofusa, Sanae Nishio, Tatsuji Enoki, Junichi Mineno, Keiya Ozawa, Hiroaki Mizukami, Kenji Ohba
    bioRxiv 2026年5月22日  最終著者責任著者
  • Yuri Ofusa, Tadahide Noguchi, Hiroaki Mizukami, Kenji Ohba
    bioRxiv 2026年4月6日  最終著者責任著者
  • Ryota Watano, Kenji Ohba, Yoshihide Sehara, Yuka Hayashi, Yasushi Saga, Masashi Urabe, Tsukasa Ohmori, Hiroaki Mizukami
    Human Gene Therapy 36(11-12) 914-924 2025年6月1日  
  • Jungo Kakuta, Kenji Ohba, Hideaki Ogasawara, Kyohei Okahara, Kazumi Emoto, Hiroaki Sako, Miho Sekai, Yasuyuki Fujita, Toshio Imai, Yogo Sakakibara
    RSC Chemical Biology 2025年  査読有り筆頭著者
    Identifying cell type-specific molecular markers on the cancer cell surface is essential for understanding cancer progression and for discovering critical neoantigens relevant to immunotherapy. Nucleic acid aptamers serve as powerful...

MISC

 29

書籍等出版物

 2

講演・口頭発表等

 55

担当経験のある科目(授業)

 2

所属学協会

 8

共同研究・競争的資金等の研究課題

 9

産業財産権

 2

メディア報道

 2

その他

 3